Community Health Center CEO Time Management: Clinical and Administrative Demands

Community health center CEO time management across clinical and administrative demands is among the most complex executive time management challenges in the nonprofit sector. Federally Qualified Health Centers (FQHCs) and look-alike organizations operate under a federal grant program that requires simultaneous performance as healthcare providers, community organizations, and government contractors. The CEO must maintain clinical quality oversight, HRSA compliance, Medicaid and Medicare billing management, community health advocacy, and board governance, all while managing an organization that may serve tens of thousands of patients annually across multiple sites.

This guide addresses the time management pressures that community health center CEO time management creates and offers a practical framework for leading effectively across the clinical and administrative dimensions of the role.

The FQHC Governance Structure and Its Time Implications

FQHCs operate under a unique governance model mandated by federal law: the board of directors must be majority patient consumers of the health center’s services. This requirement creates a governance relationship that is different from most nonprofit boards and that requires specific CEO time investment.

FQHC board management for CEOs includes:

Monthly board meetings (more frequent than most nonprofit governance models): preparation, facilitation, and follow-up
Ongoing board member education and development (patient board members may need support understanding financial statements, compliance requirements, and clinical quality metrics)
Board recruitment: maintaining majority patient representation while recruiting sufficient financial, clinical, and management expertise
HRSA Board Governing Authority compliance: ensuring the board meets all federal composition and authority requirements

The CEO who underinvests in board development for a patient-majority board creates governance risk: a board that does not understand what it is being asked to approve cannot provide genuine oversight. This is a regulatory issue (HRSA expects substantive board governance), not just a management preference.

HRSA Compliance Management

Health Resources and Services Administration (HRSA) compliance is the foundational regulatory obligation of an FQHC. HRSA Program Requirements cover 19 areas including governance, clinical services, enabling services, staffing, quality improvement, health information technology, and financial management. Collectively, these requirements define the operational boundaries within which the health center must function.

CEO time in HRSA compliance:

Annual Operational Site Visit (OSV) preparation: FQHCs undergo HRSA site reviews periodically, and preparation is a significant organizational undertaking. CEO time: oversight of preparation process, senior leadership briefings, review of final preparation materials
Ongoing compliance monitoring: the CEO should review compliance status through a dashboard or quarterly compliance report, not through direct operational involvement
HRSA Project Officer relationship: maintaining direct contact with the assigned HRSA Project Officer (typically quarterly) to surface any compliance concerns before they become formal findings
Change in Scope (CIS) requests: when the health center wants to add a new service, open a new site, or make structural changes, HRSA CIS approval is required. The CEO should be approving CIS strategy and reviewing submissions before filing

Compliance management at the operational level belongs to a Compliance Officer or a designated compliance management function. CEOs who personally manage compliance operations are filling a structural gap rather than providing executive oversight.

UDS Reporting Management

The Uniform Data System (UDS) is HRSA’s annual reporting requirement for FQHCs. UDS data covers patient demographics, clinical quality measures, staffing, and financial performance. It is both a compliance requirement and a performance management tool, because HRSA reviews UDS data to assess health center performance against quality benchmarks.

CEO time in UDS management:

Annual review of UDS data before submission: the CEO should understand the organization’s performance on key clinical quality measures and financial metrics before the data goes to HRSA
Board presentation of UDS data: the board should review UDS performance annually as part of quality oversight
Strategic response to UDS performance gaps: if quality measures are below HRSA benchmarks, the CEO should be directing the clinical quality improvement response with the CMO or Medical Director

UDS data extraction, validation, and formatting for submission is a grants management and health information technology function. The CEO’s role is reviewing the results and ensuring strategic response to performance data, not managing the submission process.

Medicaid and Medicare Billing Management

FQHCs receive prospective payment system (PPS) rates for Medicaid-covered visits, which represent a major portion of FQHC revenue. Medicare also pays FQHCs through an all-inclusive encounter rate. Managing these payment systems requires financial management expertise at the CFO and billing department level, with CEO oversight focused on strategic financial implications.

CEO financial oversight in this domain:

Monthly financial review: revenue by payer mix, claims denial rates, days in accounts receivable, and PPS rate adequacy
Annual PPS rate review and HRSA wrap submission (the process by which FQHCs access additional Medicaid payment for under-resourced services)
Payer contract negotiations for managed care organizations (MCO): the CEO should be involved in strategy and, for major MCO relationships, in the negotiation at the senior relationship level
Sliding fee scale governance: FQHCs are required to provide services on a sliding fee scale for uninsured patients. Setting and annually reviewing the sliding fee schedule is a board-approved governance function with CEO leadership

According to HRSA’s Health Center Program data, FQHCs serve over 30 million patients annually at nearly 15,000 service delivery sites, making community health centers the largest primary care safety net in the United States. The CEO bears responsibility for the financial sustainability of this safety net function in their service area.

340B Program Compliance

The 340B Drug Pricing Program allows FQHCs to purchase outpatient pharmaceuticals at significantly reduced prices. Properly managed, 340B savings can represent millions of dollars in annual benefit to an FQHC. Improperly managed, 340B compliance failures can result in program termination and significant financial penalties.

CEO time in 340B governance:

Annual 340B program review: understanding the organization’s 340B utilization, savings, and compliance posture
Board presentation of 340B program performance and compliance status
340B audit readiness: ensuring the organization has adequate 340B compliance systems and documentation to withstand HRSA or contract pharmacy audit
Strategic decisions about 340B program expansion (adding contract pharmacies, expanding eligible services)

Day-to-day 340B operations (drug procurement, contract pharmacy management, patient eligibility tracking) belong to pharmacy leadership and compliance staff. The CEO’s role is governance and strategic oversight, not 340B program management.

Clinical Quality Oversight

Clinical quality is the health center’s core mission output, and the CEO bears organizational accountability for clinical performance. However, clinical quality management is operationally a Medical Director and Quality Improvement Director function, not a CEO function.

CEO time in clinical quality:

Monthly quality dashboard review: tracking key clinical quality measures (hypertension control, diabetes management, cancer screening rates, behavioral health integration metrics) against HRSA benchmarks and organizational targets
Quarterly quality committee (or board quality committee) participation: receiving and responding to quality improvement reports
Strategic investment decisions: approving resource allocation for clinical quality initiatives (health IT upgrades, care management staffing, clinical decision support tools)
Public representation of the health center’s quality performance in community and funder contexts

The CEO who is personally involved in quality improvement project management is below the strategic level of the role. The CEO who has no visibility into clinical quality data until a HRSA site visit reveals problems has abdicated an essential oversight responsibility.

Community Health Advocacy

FQHCs are community institutions, and the CEO’s community advocacy role has both a relationship function (maintaining trust with the communities served) and a policy function (advocating for FQHC funding and policy priorities at the state and federal level).

A realistic community health advocacy time budget for an FQHC CEO:

National Health Center Week and sector advocacy days: one to two days per year in Washington for Hill visits with the National Association of Community Health Centers (NACHC) delegation
State primary care association engagement: regular participation in state-level advocacy activities (board service, testimony, coalition meetings)
Community relationship maintenance: quarterly presence at community meetings or events in the service area
Media engagement: responding to local media inquiries about community health issues and FQHC performance

Managing an FQHC CEO’s demanding schedule requires an EA with strong health sector literacy, because the scheduling complexity of multi-site clinical operations, HRSA compliance deadlines, and community advocacy commitments is substantial.

Structuring the Community Health Center CEO Calendar

A practical time allocation framework for a community health center CEO:

Clinical quality and operations oversight: 20 to 25 percent
HRSA compliance and government relations: 10 to 15 percent
Financial oversight (billing, 340B, payer relations): 10 to 15 percent
Board governance: 10 to 15 percent
Community relationships and advocacy: 10 to 15 percent
Internal leadership and staff management: 15 to 20 percent
Strategic planning and development: 10 to 15 percent

CEOs of multi-site FQHCs should also budget explicit site visit time (not operational site management, but visible leadership presence at each site) at least quarterly per site. Supporting community health center CEO effectiveness with structured administrative support helps protect the strategic time blocks that comprehensive health center governance requires.

Conclusion

Community health center CEO time management across clinical and administrative demands requires disciplined governance oversight, strategic financial management, and authentic community accountability. The FQHC CEO who invests in building strong clinical, financial, and compliance leadership below the executive level, and who protects strategic time for quality oversight, HRSA relationships, and community trust-building, creates the conditions for an organization that delivers on its mission to provide high-quality primary care to the most vulnerable patients in the community.

For further context, explore Charter School Network CEO Time Management Across Multiple Campuses and How Animal Welfare Nonprofit CEOs Manage Operational and Advocacy Time.